Adicet Bio Inc expected to post a loss of 36 cents a share - Earnings Preview

ADICET Bio

05/08/2024 12:25

* Adicet Bio Inc  ACET.OQ   ACET.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 7
(estimated) for the period ending June 30 2024
    * The Boston Massachusetts-based  company is expected to
report
revenue of $625 thousand, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Adicet Bio Inc is for a
loss
of 36 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$7.00​, above​ its last closing price of $1.44. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.38       -0.39      -0.35     Beat    9.7
 Dec. 31 2024  -0.72       -0.69      -0.69     Met     0.6
 Sep. 30 2023  -0.78       -0.74      -1.16     Missed  -57.3​
 Jun. 30 2023  -0.71       -0.68      -0.75     Missed  -10
 ​​Mar.        -0.71       -0.69      -0.72     Missed  -4.8
 31 2023                                                
 Dec. 31 2022  0.29        -0.28      -0.72     Missed  -158.1
                                                        ​
 Sep. 30 2022  -0.55       -0.53      -0.53     Met     -0.6
 Jun. 30 2022  -0.44       -0.45      -0.56     Missed  -23.1
 This summary was machine generated August 5 at 11:25 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)